Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase NA 2Phase 1/2 1

Status

Unknown 2Completed 1

Sponsor Class

NETWORK 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Head & Neck 3

Conditions

Squamous Cell Carcinoma of Head and Neck 2Locally Advanced Head and Neck HPV Negative Squamous Cell Cancers 1Hypoxia 1

Interventions

Cisplatin 144Radiotherapy 71Fluorouracil 50Radiotherapy, Intensity-Modulated 45Docetaxel 39Gemcitabine 38Cetuximab 38Carboplatin 31pembrolizumab 25Capecitabine 22Drug Therapy 17toripalimab 14Paclitaxel 14camrelizumab 10Surgical Procedures, Operative 10Nivolumab 10Chemoradiotherapy 10nimotuzumab 9Radiation 9Neoadjuvant Therapy 8Methotrexate 8Magnetic Resonance Spectroscopy 8Chemotherapy, Adjuvant 8nedaplatin 7Thyrotropin Alfa 7Platinum 7tislelizumab 6spartalizumab 6Standard of Care 6Specimen Handling 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × Nimorazole × Head & Neck × Clear all
NCT01880359 2022-05-10

AF CRT +/- Nimorazole in HNSCC

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Unknown
640 enrolled
Head & Neck

Locally Advanced Head and Neck HPV Negative Squamous Cell Cancers

NCT01950689 2021-10-19

NIMRAD

The Christie NHS Foundation Trust

Phase 3 Completed
338 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT02661152 2021-04-13

DAHANCA30

Danish Head and Neck Cancer Group

Phase 3 Unknown
1,252 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Hypoxia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡